CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 21.00 thousand shares for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 21.00K shares, a 81.42% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 113.00K shares, a 13.08% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 130.00K shares, a 39.25% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 214.00K shares, a 33.75% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2025-12-27 | 21.00K shares 10-K · filed 2026-02-18 |
| 2024-12-28 | 113.00K shares 10-K · filed 2025-02-19 |
| 2023-12-30 | 130.00K shares 10-K · filed 2024-02-14 |
| 2022-12-31 | 214.00K shares 10-K · filed 2023-02-22 |
| 2021-12-25 | 160.00K shares 10-K · filed 2022-02-16 |
| 2020-12-26 | 292.00K shares 10-K · filed 2021-02-17 |
| 2019-12-28 | 454.00K shares 10-K · filed 2020-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |